A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema

PHASE3CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Macular EdemaDiabetic MellitusRetinal Disease
Interventions
DRUG

pegaptanib sodium

Intravitreal injection of 0.3 mg every 6 weeks

OTHER

sham injection

sham injection every 6 weeks

Trial Locations (43)

Unknown

Nagoya City University Hospital, Nagoya

Nagoya University Hospital, Nagoya

National Hospital Organization Nagoya Medical Center, Nagoya

Akita University Hospital, Akita

Aomori Prefectural Chuo Hospital, Aomori

Chiba University Hospital, Chiba

Juntendo University Hospital Urayasu, Ophthalmology, Urayasu-shi

Hayashi Eye Hospital, Fukuoka

Kyushu University Hospital, Fukuoka

Murakami Karindo Hospital, Fukuoka

Ohshima Hospital of Ophthalmology, Fukuoka

St. Mary's Hospital, Kurume

Fukushima Medical University Hospital, Fukushima

Gunma University Hospital, Maebashi

Kimura Eye & Internal Medicine Hospital, Kure

Asahikawa Medical College Hospital, Asahikawa

Yoshida Eye Hospital, Hakodate

Hokkaido University Hospital, Sapporo

Hyogo Prefectural Amagasaki Hospital, Amagasaki

Kobe City Medical Center General Hospital, Kobe

Kohnan Hospital, Kobe

Hitachi General Hospital, Hitachi

Mito Kyodo General Hospital, Mito

Kagawa University Hospital, Kida-gun

Kagoshima University Hospital, Kagoshima

Ideta eye hospital, Kumamoto

Kyoto University Hospital, Kyoto

NTT East Tohoku Hospital, Sendai

Shinshu University Hospital, Matsumoto

Nara Medical University Hospital, Kashihara

Niigata University Medical and Dental Hospital, Niigata

Osaka City University Hospital, Osaka

Osaka general medical center, Osaka

Osaka Saiseikai Izou Hospital, Osaka

Kinki University Hospital, Anesthesiology, Osaka-sayama-shi

Saga Prefectural Hospital Koseikan, Saga

Shiga University of Medical Science Hospital, Ōtsu

Seirei Hamamatsu General Hospital, Hamamatsu

Nihon University Surugadai Hospital, Chiyoda-ku

Ochanomizu Inoue Eye Clinic, Chiyoda-ku

National Hospital Organization Tokyo Medical Center, Meguro-ku

Keio University Hospital, Shinjuku-ku

Hirota Eye Clinic, Shūnan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY